Congress Begins
  • in 202 days
  • Scientific Program

    Please check back later for further information. Please contact ish2018-speakers at icsevents.com for further information.

    ThursdaySeptember 13, 2018

    • 08:30 - 10:00

      Venous Thromboembolic Disease

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • HIT and DIC: Unraveling the Causes of Ischemic Limb Injury Dr. Ted Warkentin, Canada
      • Management of Cancer-Associated Thrombosis: Dr. Cynthia Wu, Canada
    • 10:30 - 12:00

      Multiple Myeloma

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Antibody Therapies in Multiple Myeloma: Dr. Kevin Song, Canada
      • Developing a Rational Approach to the Treatment of Multiple Myeloma: Dr. Joseph Mikhael, USA
      • Understanding the Genetic Changes in Myeloma: Dr. Brian Walker, USA
    • 13:30 - 15:00

      ISH-ASH Joint Symposium: Targeted Therapies in Hematology

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Gene Inhibitor Therapy in AML: Dr. Donna Hogge, Canada
      • JAK inhibition in Chronic MPDs: Dr. Ruben Mesa, USA
      • CRISPR/Cas9 Genome Editing in Hemoglobinopathies: Dr. Fabien Touzot, Canada
    • 15:00 - 16:00

      Special Hematology Session: Nuclear Terrorism

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s): Dr. Robert P. Gale, UCLA/UK
    • 16:00 - 17:30

      Plenary Session – Best Abstracts

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):

    FridaySeptember 14, 2018

    • 13:30 - 15:00

      Benign Cytopenias

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Controversies in the Management of ITP: Dr. Adrian Newland, UK
      • Clonal Hematopoiesis in Congenital Neutropenia/G-CSF in Cyclic Neutropenia Dr. David Dale, USA
    • 15:30 - 17:00

      Hodgkin Lymphoma

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Will Brentuximab Vedotin & Nivolumab Improve Survival in Relapsed/Refractory Hodgkin Lymphoma?: Dr. Alina Gerrie, Canada
      • Treatment of Grey Zone Lymphomas : Dr. Joseph Connors, Canada
      • Is There a Role for Allogeneic Stem Cell Transplantation in Hodgkin Lymphoma?; Dr. John Kuruvilla, Canada
    • 15:30 - 17:00

      Chronic Myeloid Leukemia

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Choosing the Best Frontline Agent in CML: Dr. Jeff Lipton, Canada
      • Molecular mechanisms Underlying the Pathogenesis and Transformation in CML: Dr. Pierre Laneuville, Canada
      • When is it Safe to Discontinue TKIs? Dr. Donna Forrest, Canada
    • 15:30 - 17:00

      Eosinophils, Mast cells & Histiocytes

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • New Insights into the Molecular Genetics of Non-Langerhans Histiocytosis: Dr. Julien Haroche, France
      • Management of Mast cell Disease: Indolent, Smoldering & Aggressive: Dr. Animesh Pardanani, USA
      • Eosinophilic diseases: Dr. Luke Chen, Canada
    • 17:00 - 18:00

      Special Session: Case Presentations

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s): Drs. Thomas Nevill & Monika Hudoba , Canada
    • 07:30 - 08:30

      Meet-the-Expert Session

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • HIT: Dr. Ted Warkentin, Canada
    • 07:30 - 08:30

      Meet-the-Expert Session

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Treatment of Post-Autograft Relapse of Hodgkin Lymphoma: Dr. Joseph Connors, Canada
    • 08:30 - 10:00

      Acute Myelogenous Leukemia

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Prognostic Stratification in AML: Dr. Roland Walter, USA
      • Germline Mutations Associated With Myeloid Neoplasms: Dr. Akiko Shimamura, USA
      • Determining the Optimal Treatment for Patients with AML: Dr. Andre Schuh, Canada
    • 08:30 - 10:00

      Acquired Coagulopathies

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Treatment of Acquired Hemophilia A: Rebecca Kruse-Jarres, USA
      • Managing the Hemostatic Defects of Massive Transfusion Syndrome: Dr. Andrew Shih, Canada
      • Controlling Hemorrhage in a Patient with Liver Disease: Dr. Jody Kujovich, USA
    • 08:30 - 10:00

      Developments in Apheresis

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • One of the TMAs: Current Approaches and Management of Thrombotic Thrombocytopenic Purpura: Dr. Gail Rock, Canada
      • Stem Cell Mobilization Strategies: Dr. Gayatri Sreenivasan, Canada
      • Extracorporeal Photopheresis for Treatment of Graft-versus-Host Disease: Dr. Raewyn Broady, Canada
    • 10:30 - 12:00

      Stem Cell and Telomere Biology

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • What We Know About AML Stem Cells: Dr. Donna Hogge, Canada
      • Telomeres in Health and Disease: Dr. Peter Lansdorp, Canada
    • 10:30 - 12:00

      Inherited Bleeding Disorders

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Molecular Genetics of Von Willebrand’s Disease: Dr. David Lillicrap, Canada
      • Management of the Undefined Bleeding Disorder : Dr. Shannon Jackson, Canada
      • Antibody Therapy in Hemophilia: Dr. Guy Young, USA
    • 10:30 - 12:00

      Aggressive Non Hodgkin Lymphoma

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Checkpoint Inhibitors in Lymphoma: Dr. Kerry Savage, Canada
      • Treatment of Relapsed/Refractory Primary CNS Lymphoma: Dr. Doug Stewart, Canada
      • Management of Double and Triple-Hit Lymphomas: Dr. David Scott, Canada
    • 13:30 - 15:00

      Chronic Lymphocytic Leukemia

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Pathogenesis & Risk Factors for CLL: Dr. Cynthia Toze, Canada
      • Which Therapy is Best for del(17p) CLL: Ibrutinib or Ventoclax: Dr. Laurie Sehn, Canada
      • Where Does Allogeneic Transplantation Fit in the Management of CLL?: Dr. Cynthia Toze, Canada
    • 13:30 - 15:00

      Advances in the Treatment of Hemoglobinopathies

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Hydroxyurea, Transfusions & Supportive Care in Sickle Cell Anemia: Dr. Nancy Robitaille, Canada
      • Allogeneic Stem Cell Transplantation in Hemoglobinopathies: Dr. Christina Peters, Austria
      • New Therapies in ß Thalassemia: Dr. Richard Ward, Canada

    SaturdaySeptember 15, 2018

    • 13:30 - 15:00

      Advances in Allogeneic Stem Cell Transplantation

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Post-transplantation Cyclophosphamide in Unrelated Donor SCT: Dr. Marco Mielcarek, USA
      • Is Haploidentical Transplantation the Way of the Future? Dr. Robert Gale, UK
    • 13:30 - 15:00

      Hematology in the Developing World

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Improving the Outcomes for Leukemia & Lymphoma in Developing Countries: Dr. David Gomez Almaguer, Mexico
      • Systematic Analysis of Global Anemia: Dr. Nicholas Kassebaum, USA
      • Helminthic Disease of the Lungs in Immunocompromised Patients: Dr. Alissa Wright, Canada
    • 15:30 - 17:00

      Myelodysplastic Syndromes

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • The Role of Next Generation Sequencing in Prognosis: Dr. Rafael Bejar, USA
      • Novel Therapies in Low and High-Risk MDS: Dr. Mikkael Sekeres, Canada
      • Management of Iron Overload in MDS: Dr. Heather Leitch, Canada
    • 15:30 - 17:00

      Laboratory Hematology

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Laboratory Investigation of Disorders of Platelet Function: Dr. Catherine Hayward, Canada
      • MRD Testing by Flow Cytometry in Acute Myeloid Leukemia: Dr. Roland Walter, USA
      • Hemoglobinopathies - Current Screening and Diagnostic Practices: Dr. Nicholas Au, Canada
    • 15:30 - 17:00

      Congenital Disorders With Hematologic Significance

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Diagnosis and Management of Gaucher Disease: Dominick Amato, Canada
      • Familial Hemophagocytic Lymphohistiocytosis: David Dix, Canada
    • 07:30 - 08:30

      Meet-the –Expert

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Deciding on Post-Transplant Maintenance in Multiple Myeloma: Dr. Joseph Mikhael, USA
    • 07:30 - 08:30

      Meet-the –Expert

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Management of Aplastic Anemia Unresponsive to Cyclosporine/ATGAM: Dr. Phillip Scheinberg, Brazil
    • 08:30 - 10:00

      Bone Marrow Failure

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Etiology, Pathogenesis & Initial Therapy of Aplastic Anemia: Dr. Phillip Scheinberg, Brazil
      • GATA2 Mutation Disorders/Telomeropathies: Dr. Thomas Nevill, Canada
      • Treatment of Cyclosporine-Refractory Large Granular Lymphocyte Leukemia: Dr. Thomas Loughran, USA
    • 08:30 - 10:00

      Obstetric Hematology

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Treatment of Lymphoma in Pregnancy: Dr. David Scott, Canada
      • Management of Thrombocytopenia in Pregnancy: Dr. Leslie Zypchen, Canada
      • Navigating Pregnancy in a Woman with Von Willebrands Disease: Dr. Jody Kujovich, USA
    • 08:30 - 10:00

      Transfusion Medicine

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Transfusion Outcomes after Short and Long-term Blood Storage: Professor Nancy Heddle, Canada
      • Thresholds for Red Cell and Platelet Transfusions in Acute Leukemia Patients: Dr. Andrew Shih, Canada
      • Transfusion-Related Acute Lung Injury: Risk factors, Management & Prevention: Dr. Tanya Petraszko, Canada
    • 10:30 - 12:00

      Red Cell Disorders

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Management of Pure Red Cell Aplasia: Dr. Robert Means, USA
      • Megaloblastic Anemias: Why Are They Still Important?: Dr. Ralph Green, USA
      • A Practical Approach to Hyperferritinemia: Dr. Luke Chen, Canada
    • 10:30 - 12:00

      Indolent Lymphoproliferative Disorders

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Can Transformation be Predicted in Follicular Lymphoma?: Dr. Laurie Sehn, Canada
      • Can We Agree on Optimal Management of Mantle Cell Lymphoma: Dr. John Kuruvilla, Canada
      • BRAF Inhibitors in Hairy Cell Leukemia: Dr. Michael Grever, USA
    • 10:30 - 12:00

      Acute Lymphoblastic Leukemia

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • New Insights into the Genetics of Childhood ALL: Dr. Kirk Schultz, Canada
      • Antibody Therapies in ALL: Dr. Elias Jabbour, USA
      • CAR T-cell therapy in ALL: Dr. Shannon Maude, USA
    • 13:30 - 15:00

      Rare Plasma Cell Disorders

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Monoclonal Gammopathy with Renal Significance: Dr. Joseph Mikhael, USA
      • Modern Management of AL-Amyloidosis: Dr. Kevin Song, Canada
      • Overview of IgG-4 Disease: Dr. Mollie Carruthers, Canada

    SundaySeptember 16, 2018

    • 07:30 - 08:30

      Meet-the-Expert Session

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • The Problematic ITP Patient: Dr. Adrian Newland, UK
    • 07:30 - 08:30

      Meet-the-Expert Session

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Treatment of MDS with a High-risk Molecular Profile: Dr. Mikkael Sekeres, USA
    • 08:30 - 10:00

      Complement Disorders

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • New Genetic Insights and Evolving Therapies for Paroxysmal Nocturnal Hemoglobinuria: Dr. Christopher Patriquin, Canada
      • Diagnosis and Management of Atypical Hemolytic Uremic Syndrome: Dr. Gayatri Sreenivasan, Canada
      • Complement Activation in Anti-Phospholipid antibody Syndrome: Dr. Christopher Patriquin, Canada
    • 08:30 - 10:00

      Myeloproliferative Disorders

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • The Role of Ruxolitinib in Polycythemia Vera: Dr. Lynda Foltz, Canada
      • Prognostic Factors in Myelofibrosis and Essential Thrombocytosis: Ruben Mesa, USA
    • 10:30 - 12:00

      Disorders of Platelet Number and Function

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Use of Genomics to Uncover Novel Inherited Platelet Disorders: Dr. Jacob Rozmus, Canada
      • Causes and Consequences of Constitutional Platelet Dysfunction: Catherine Hayward, Canada
    • 10:30 - 12:00

      Autologous Stem Cell Transplantation

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s):
      • Autologous SCT for Multiple Sclerosis: Dr. Natasha Kekre, Canada
      • Cell Dose Thresholds for Autologous SCT: Dr. Maryse Power, Canada
    • 12:00 - 12:30

      Closing Session: Key Take-Home Messages

      Location: Room TBD, East Building, Vancouver Convention Centre
      Chair(s): Dr. Thomas Nevill & Dr. Gail Rock , Canada